Vanguard Group
ACER

Vanguard Group’s Acer Therapeutics Inc ACER Stock Holding History

Vanguard Group’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-474,094
Closed -$386K – 4564
2023
Q3 		$386K Buy
474,094
+59,029
+14% +$48.5K ﹤0.01% 4127
2023
Q2 		$383K Hold
415,065
– – ﹤0.01% 4189
2023
Q1 		$315K Buy
415,065
+76,691
+23% +$151K ﹤0.01% 4233
2022
Q4 		$849K Buy
338,374
+59,740
+21% +$103K ﹤0.01% 3960
2022
Q3 		$387K Sell
278,634
-1,785
-0.6% -$2.58K ﹤0.01% 4285
2022
Q2 		$353K Buy
280,419
+2,204
+0.8% +$4.62K ﹤0.01% 4367
2022
Q1 		$807K Buy
278,215
+99,335
+56% +$240K ﹤0.01% 4275
2021
Q4 		$408K Sell
178,880
-2,860
-2% -$6.64K ﹤0.01% 4464
2021
Q3 		$465K Buy
181,740
+2,597
+1% +$6.59K ﹤0.01% 4389
2021
Q2 		$512K Buy
179,143
+11,094
+7% +$31.9K ﹤0.01% 4265
2021
Q1 		$523K Buy
168,049
+52,946
+46% +$180K ﹤0.01% 4126
2020
Q4 		$301K Sell
115,103
-7,924
-6% -$21.3K ﹤0.01% 4039
2020
Q3 		$354K Sell
123,027
-18,000
-13% -$58.2K ﹤0.01% 3871
2020
Q2 		$483K Sell
141,027
-28,521
-17% -$80.5K ﹤0.01% 3775
2020
Q1 		$338K Buy
169,548
+256
+0.2% +$938 ﹤0.01% 3758
2019
Q4 		$679K Sell
169,292
-98
-0.1% -$333 ﹤0.01% 3734
2019
Q3 		$540K Sell
169,390
-108,573
-39% -$318K ﹤0.01% 3801
2019
Q2 		$1.08M Buy
277,963
+14,337
+5% +$273K ﹤0.01% 3651
2019
Q1 		$6.41M Buy
263,626
+12,297
+5% +$290K ﹤0.01% 3045
2018
Q4 		$5.06M Buy
251,329
+7,296
+3% +$168K ﹤0.01% 3082
2018
Q3 		$7.53M Buy
244,033
+231,822
+1,898% +$6.21M ﹤0.01% 3064
2018
Q2 		$264K Hold
12,211
– – ﹤0.01% 3935
2018
Q1 		$231K Buy
+12,211
New +$224K ﹤0.01% 3936
2017
Q3 		– Sell
-7,915
Closed -$54K – 4076
2017
Q2 		$54K Sell
7,915
-1,810
-19% -$12K ﹤0.01% 4023
2017
Q1 		$77K Buy
9,725
+2,184
+29% +$21.5K ﹤0.01% 4002
2016
Q4 		$73K Sell
7,541
-8,721
-54% -$153K ﹤0.01% 3998
2016
Q3 		$547K Buy
16,262
+484
+3% +$20.3K ﹤0.01% 3741
2016
Q2 		$679K Buy
15,778
+830
+6% +$24.7K ﹤0.01% 3715
2016
Q1 		$361K Buy
14,948
+341
+2% +$7.47K ﹤0.01% 3853
2015
Q4 		$423K Buy
14,607
+432
+3% +$14.3K ﹤0.01% 3874
2015
Q3 		$462K Buy
14,175
+677
+5% +$23.9K ﹤0.01% 3871
2015
Q2 		$501K Buy
13,498
+2,569
+24% +$98.7K ﹤0.01% 3860
2015
Q1 		$501K Buy
10,929
+3,348
+44% +$205K ﹤0.01% 3829
2014
Q4 		$455K Hold
7,581
– – ﹤0.01% 3762
2014
Q3 		$627K Buy
7,581
+93
+1% +$11K ﹤0.01% 3652
2014
Q2 		$1.04M Hold
7,488
– – ﹤0.01% 3473
2014
Q1 		$1.15M Buy
7,488
+5,014
+203% +$761K ﹤0.01% 3409
2013
Q4 		$375K Buy
2,474
+1,428
+137% +$232K ﹤0.01% 3658
2013
Q3 		$191K Hold
1,046
– – ﹤0.01% 3704
2013
Q2 		$132K Buy
+1,046
New +$153K ﹤0.01% 3698

Other funds holding ACER

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Vanguard Group's ACER Position: Q4 2023 in Review

Vanguard Group sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 474,094 shares — an estimated $386K sold.

Vanguard Group first reported a position in ACER in Q2 2013 and held it in 40 quarters. The position peaked at $7.53M in Q3 2018. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.

  • Vanguard Group reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
  • Vanguard Group sold 474,094 Acer Therapeutics Inc shares in Q4 2023, an estimated $386K.
  • Vanguard Group first reported a position in Acer Therapeutics Inc in Q2 2013 and held it in 40 quarters.
  • Vanguard Group's Acer Therapeutics Inc position peaked at $7.53M in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.

Based on Vanguard Group's 13F filing for Q4 2023, filed 14 Feb 2024.